The promotion of eosinophil degranulation and adhesion to conjunctival epithelial cells by IgE-activated conjunctival mast cells

Annals of Allergy, Asthma and Immunology

Volumn 92, Issue 1, 2004, Pages 65-72

  Cook, Ellen B ^a   Stahl, James L ^a,b   Sedgwick, Julie B ^a   Barney, Neal P ^a   Graziano, Frank M ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b University of Wisconsin Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EOSINOPHIL PEROXIDASE; IMMUNOGLOBULIN E; NEUROTOXIN; OLOPATADINE;

ARTICLE; CELL ACTIVATION; CELL ADHESION; CONJUNCTIVA EPITHELIUM; CONTROLLED STUDY; DEGRANULATION; ENZYME ACTIVITY; ENZYME ASSAY; EOSINOPHIL; HUMAN; HUMAN CELL; HUMAN TISSUE; MAST CELL; MEDIATOR RELEASE; PRIORITY JOURNAL; RADIOIMMUNOASSAY;

EID: 1642495888     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)61712-7     Document Type: Article

References (43)

1. Abelson MB, Baird RS, Allansmith MR. Tear histamine levels in vernal conjunctivitis and other ocular inflammations. Ophthalmology. 1980;87:812-814.
2. Butrus SI, Ochsner KI, Abelson MB, Schwartz LB. The level of tryptase in human tears: an indicator of activation of conjunctival mast cells. Ophthalmology. 1990;97:1678-1683.
3. Galli SJ. Mast cells and basophils. Curr Opin Hematol. 2000;7:32-39.
4. Cook EB, Stahl JL, Barney NP, Graziano FM. Ocular mast cells: characterization in normal and disease states. Clin Rev Allergy Immunol. 2001;20:243-268.
5. Leonardi A, Borghesan F, Avarello A, et al. Effect of lodoxamide and disodium cromoglycate on tear eosinophil cationic protein in vernal keratoconjunctivitis. Br J Ophthalmol. 1997;81:23-26.
6. Hoyos L, Norris A, Vargaftig BB. Effects of nedocromil sodium on antigen-induced conjunctivitis in guinea pigs. Adv Ther. 2000;17:1-6.
7. Miyoshi T, Fukagawa K, Shimmura S, et al. Interleukin-8 concentrations in conjunctival epithelium brush cytology samples correlate with neutrophil, eosinophil infiltration, and corneal damage. Cornea. 2001;20:743-747.
8. Bonini S, Bonini S, Lambiase A, et al. Vernal keratoconjunctivitis: a model of 5q cytokine gene cluster disease. Int Arch Allergy Immunol. 1995;107:95-98.
9. Leonardi A, Borghesan F, Faggian D, et al. Eosinophil cationic protein in tears of normal subjects and patients affected by vernal keratoconjunctivitis. Allergy. 1995;50:610-613.
10. Montan PG, van Hage-Hamsten M. Eosinophil cationic protein in tears in allergic conjunctivitis. Br J Ophthalmol. 1996;80:556-560.
11. Oh JW, Shin JC, Jang SJ, Lee HB. Expression of ICAM-1 on conjunctival epithelium and ECP in tears and serum from children with allergic conjunctivitis. Ann Allergy Asthma Immunol. 1999;82:579-585.
12. Sharif NA, Xu SX, Magnino PE, Pang I-H. Human conjunctival epithelial cells express histamine-1 receptors coupled to phosphoinositide turnover and intracellular calcium mobilization: roll in ocular allergic and inflammatory diseases. Exp Eye Res. 1996;63:169-178.
13. Cook EB, Stahl JL, Barney NP, Graziano FM. Olopatadine inhibits anti-IgE stimulated conjunctival mast cell upregulation of ICAM-1 expression on conjunctival epithelial cells. Ann Allergy Asthma Immunol. 2001;87:424-429.
14. Stahl JL, Cook EB, Barney NP, Graziano FM. Differential and cooperative effects of TNFα, IL-1β and IFNγ on human conjunctival epithelial cell receptor expression and chemokine release. Invest Ophthalmol Vis Sci. 2003;44:2010-2015.
15. Baudouin C, Haouat N, Brignole F, et al. Immunopathological findings in conjunctival cells using immunofluoreseence staining of impression cytology specimens. Br J Ophthalmol. 1992;76:545-549.
16. Baudouin C, Brignole F, Becquet F, et al. Flow cytometry in impression cytology specimens: a new method for evaluation of conjunctival inflammation. Invest Ophthalmol Vis Sci. 1997;38:1458-1464.
17. Whitcup SM, Chan CC, Kozhich AT, Magone MT. Blocking ICAM-1 (CD54) and LFA-1 (CD11a) inhibits experimental allergic conjunctivitis. Clin Immunol. 1999;93:107-113.
18. Miller S, Cook E, Graziano FM, et al. Human conjunctival mast cell responses in vitro to various secretagogues. Ocul Immunol Inflamm. 1996;4:39-49.
19. Cook EB, Stahl JL, Barney NP, Graziano FM. Olopatadine inhibits TNFα release from human conjunctival mast cells. Ann Allergy Asthma Immunol. 2000;84:505-508.
20. Sharif NA, Xu SX, Miller ST, et al. Characterization of the ocular antiallergic and antihistaminic effects of olopatadine (AL-4943A), a novel drug for treating ocular allergic diseases. J Pharm Exp Ther. 1996;278:1252-1261.
21. Cook EB, Stahl JL, Miller S, et al. Isolation of human conjunctival mast cells and epithelial cells: tumor necrosis factor-α from mast cells affects intercellular adhesion molecule-1 expression on epithelial cells. Invest Ophthalmol Vis Sci. 1998;39:336-343.
22. Stahl JL, Cook EB, Graziano FM, Barney NP. Conjunctival mast cell mediated upregulation of ICAM-1 and IL-8 release from human conjunctival epithelial cells are differentially regulated. J Allergy Clin Immunol. 2001;107:S173.
23. Yamamoto H, Sedgwick JB, Busse WW. Differential regulation of eosinophil adhesion and transmigration by pulmonary microvascular endothelial cells. J Immunol. 1998;161:971-977.
24. Kita H, Weiler DA, Abu-Ghazaleh R, et al. Release of granule proteins from eosinophils cultured with IL-5. J Immunol. 1992;149:629-635.
25. Bonini S, Magrini L, Rotiroti G, et al. The eosinophil and the eye. Allergy. 1997;52:44-47.
26. Adamako D, Lacy P, Moqbel R. Mechanisms of eosinophil recruitment and activation. Curr Allergy Asthma Rep. 2002;2:107-116.
27. Matsumoto K, Appiah-Pippim J, Schleimer RP, et al. CD44 and CD69 represent different types of cell-surface activation markers for human eosinophils. Am J Respir Cell Mol Biol. 1998;18:860-866.
28. Sanmugalingham D, De Vries E, Gauntlett R, et al. Interleukin-5 enhances eosinophil adhesion to bronchial epithelial cells. Clin Exp Allergy. 2000;30:255-263.
29. Olszewska-Pazdrak B, Pazdrak K, Ogra PL Garofalo RP. Respiratory syncytial virus-infected pulmonary epithelial cells induce eosinophil degranulation by a CD18-mediated mechanism. 1998;160:4889-4895.
30. Sato M, Takizawa H, Kohyama T, et al. Eosinophil adhesion to human bronchial epithelial cells: regulation by cytokines. Int Arch Allergy Immunol. 1997;113:203-205.
31. Carreno MP, Chomont N, Kazatchkine MD, et al. Binding of LFA-1 (CD 11a) to intercellular adhesion molecule 3 (ICAM-3; CD50) and ICAM-2 (CD102) triggers transmigration of human immunodeficiency virus type 1-infected monocytes through mucosal epithelial cells. J Virol. 2002;75:32-40.
32. Pesce G, Ciprandi G, Buscaglia S, et al. Preliminary evidence for "aberrant" expression of the leukocyte integrin LFA-1 (CD11a/CD18) on conjunctival epithelial cells of patients with mite allergy. Int Arch Allergy Immunol. 2001;125:160-163.
33. Miyake K, Underhill CB, Lesley J, Kincade PW. Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition. J Exp Med. 1990;172:69-75.
34. Lazaar AL, Albelda SM, Pilewski JM, et al. T lymphocytes adhere to airway smooth muscle cells via integrins and CD44 and induce smooth muscle cell DNA synthesis. J Exp Med. 1994;180:807-816.
35. Kalesnikoff J, Lam V, Krystal G. SHIP represses mast cell activation and reveals that IgE alone triggers signaling pathways which enhance normal mast cell survival. Mol Immunol. 2001;38:1201-1206.
36. Sada K, Shahjahan Miah SM, Maeno K, et al. Regulation of FcεRI-mediated degranulation by an adaptor protein 3BP2 in rat basophilic leukemia RBL-2H3 cells. Blood. 2002;100:2138-2144.
37. Ohmori K, Hayashi K, Kaise T, et al. Pharmacological, pharmacokinetic and clinical properties of olopatadine hydrochloride, a new antiallergic drug. Jpn J Pharmacol. 2002;88:379-397.
38. Ikemura T, Manabe H, Sasaki Y, et al. KW-4679, an antiallergic drug, inhibits the production of inflammatory lipids in human polymorphonuclear leukocytes and guinea pig eosinophils. Int Arch Allergy Immunol. 1996;110:57-63.
39. Miyake K, Horikoshi K, Ikeda Y, et al. Inhibitory effect of olopatadine hydrochloride (KW-4679), a novel antiallergic drug, on peptide leukotriene release from human eosinophils. Allergol Int. 2001;50:113-116.
40. Hingorani M, Calder V, Jolly G, et al. Eosinophil surface antigen expression and cytokine production vary in different ocular allergic diseases. J Allergy Clin Immunol. 1998;102:821-830.
41. Levi-Schaffer F, Temkin V, Simon HU, et al. Proteomic analysis of human eosinophil activation mediated by mast cells, granulocyte macrophage colony stimulating factor and tumor necrosis factor a. Proteomics. 2002;2:1616-1626.
42. Takafuji S, Tadokoro K, Ito K, Nakagawa T. Release of granule proteins from human eosinophils stimulated with mast-cell mediators. Allergy. 1998;53:951-956.
43. Temkin V, Kantor B, Weg V, et al. Tryptase activates the mitogen-activated protein kinase/activator protein-1 pathway in human peripheral blood eosinophils, causing cytokine production and release. J Immunol. 2002;169:2662-2669.